难治性咳嗽变异型哮喘的诊治体会被引量：3

下载PDF

导出

摘要目的观察应用舒利迭(沙美特罗.丙酸氟替卡松)吸入剂联合顺尔宁(孟鲁司特钠片)治疗难治性咳嗽变异型哮喘的临床疗效。方法将2006年1月至2010年1月我院收治的38例难治性咳嗽变异型哮喘患者随机分为治疗组20例和对照组18例,两组患者在年龄、性别、咳嗽时间等方面差异无统计学意义(P>0.05),具有可比性。对照组采用常规治疗,治疗组吸入舒利迭及服用顺尔宁治疗。结果治疗组总有效率为95.00%,对照组总有效率为27.78%,两组比较差异有统计学意义(P<0.05)。结论使用吸入舒利迭及服用顺尔宁治疗难治性咳嗽变异型哮喘,效果明显于单纯使用常规治疗,能缩短病程、提高疗效,值得临床推广应用。

作者许俊旭

机构地区海口市琼山人民医院呼吸内科

出处《海南医学》 CAS 2011年第21期61-62,共2页 Hainan Medical Journal

关键词难治性咳嗽变异型哮喘舒利迭顺尔宁诊治体会

分类号 R562.25 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献9

1殷凯生.难治性呼吸系统疾病[M].上海:上海科学技术出版社,2007:116-146.
2中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(草案).中华结核和呼吸杂志,2009,32(6):355-358.
3难治性哮喘诊断与处理专家共识[J].中华结核和呼吸杂志,2010,33(8):572-577. 被引量：139
4叶任高.内科学[M].北京：人民卫生出版社,2002.32.
5赖克方,钟南山.慢性咳嗽[M].北京:人民卫生出版社,2009:161-165.263-265.
6林士军,王桂杰,刘玉春,董惠翔.舒利迭治疗支气管哮喘的临床观察[J].临床肺科杂志,2009,14(2):188-189. 被引量：78
7Sebaldt RJ, Sheller JR, Oatcs JA, et al. inhibition of eicosanoid biosynthesis by glucocortooids in humans [J]. Proc Natl Acad Sci USA, 1990, 87(18): 6974-6978.
8Drazen JM, O' Brien J, Sparrow D, ct al. Recovery of lcuko~enc E4 from the urine of patients with airway obs~uction [J]. AM revrcspir Dis, 1992, 146(1): 104-108.
9潜丽俊,杨丽军,刘晟.顺尔宁治疗及预防咳嗽变异性哮喘的疗效观察[J].浙江临床医学,2002,4(4):256-257. 被引量：36

二级参考文献17

1段建明,安新,张继艳.沙美特罗联合氟替卡松治疗咳嗽变异型哮喘38例临床观察[J].临床肺科杂志,2006,11(6):714-714. 被引量：29
2Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immuno1,2004, 115 ( 1 ) :59 -65.
3Bousquet J, Jeffery PK. Busse WW, et al. Asthma from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med,2000,161 (5) :1720 -1745.
4Van den Berg N J, Ossip MS, Hederos CA, et al. Salmeterol/fluticasone propionate (50/100 micog) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Pediatric Pulmonology ,2000,30 (2) :97 - 105.
5Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med, 2004,170 ( 8 ) : 836 - 844.
6Dahl R, Chuchalin A, Gor D, et al. EXCEL: A randomised trial comparing salmeteroL/fluticasone propionate and formoterolfbudesonide combinations in adults with persistent asthma. Respir Med, 2006,100(7) :1152 - 1162.
7GINA 2006. http://www. ginasthma, com.
8Jeannin P, Lecoanet S, Delneste Y, et al. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol, 1998,160 (7) :3555 -3561.
9Parks DP, Ahrens RC, Humphries T, et al. Chronic cough in child- hood: approach to diagnosis and treatment. J Pediatr. 1989,115:856.
10Villaran C,O'Neil SJ, Helbiling A, et al. Montelukast versus Salmeterol in patients with asthma and exercise- induced bronchoconstriction. J Allergy clin Immunol, 1999,104:547～ 553.